Clonal derivatives 8 and 11 of the T47D human breast carcinoma cell line release particles that have the biochemical characteristics of a retrovirus. Particles recovered from cultures of [3H]uridine-labeled clone 11 had a density of 1.18 g/ml and contained 60-70S and 35S RNAs associated with reverse transcriptase activity. The production of these particles was steroid-dependent. Clone 8 particles had a higher density, 1.195 g/ml, and their production was independent of steroid hormone. By RIA, antigens crossreactive with the 52,000-dalton envelope glycoprotein gp52, the major external protein of mouse mammary tumor virus, were found associated with these particles and in the media. Most of the gp52-related antigen was in soluble form, but it was enriched in the particle preparation. A lesser amount of antigen was distributed within the cultured cells. Absorption of rabbit antibody to gp52 with clone 11 particle preparations eliminated the ability of this antibody to detect immunocytochemically a crossreactive antigen previously localized in tissue sections of human breast carcinoma. These results indicate that the particle isolates from T47D contain the same gp52-related antigen found in human breast carcinomas and constitute an excellent source for the purification and characterization of this antigen.Previous studies (1)(2)(3)(4) To this end, it was of interest to resolve certain issues regarding the nature of the crossreactivity observed between gp52 and the unique antigens found in human breast cancers. Our experience indicated that it was unlikely that the supply of surgically removed human tumors would provide sufficient antigen for the necessary biochemical studies. Therefore, we focused on the T47D cell line, which had been established from the pleural effusion of a patient with intraductal and invasive carcinoma of the breast (13).It is the purpose of the present paper to present data on the T47D cell line and its clonal derivatives that reproducibly secrete virus-like particles containing the gp52-related antigen. This situation solves the difficult logistic problem of making available a reliable source of material from which to purify the relevant breast cancer antigens with comparative ease.
MATERIALS AND METHODSCells. The cells were grown in RPMI 1640 medium containing fetal calf serum (10%), insulin (0.2 unit/ml), glutamine (2 mM), streptomycin (100 pug/ml), penicillin (100 units/ ml), and mycostatin (25 ,g/ml). When the cells were grown in the presence of steroid hormones, the fetal calf serum was dialyzed.For virus collection, the cells were seeded in RPMI 1640 medium containing 10% fetal calf serum for 24 hr followed by medium containing 5% dialyzed fetal calf serum and 1 nM 17-estradiol. After one medium change, this medium was replaced by one containing 10 nM progesterone free of fetal calf serum (day 5 after passage). From day 6, medium was collected every day, and the cells were refed with progesterone-containing medium. The collected medium was clarified by centrifugation for 15 mi...